Jane Street
CODX

Jane Street’s Co-Diagnostics CODX Stock Holding History

Jane Street’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,130
Closed -$5.72K – 11760
2025
Q4 		$5.72K Buy
1,130
+570
+102% +$6.2K ﹤0.01% 10894
2025
Q3 		$5.78K Buy
+560
New +$5.21K ﹤0.01% 10605
2022
Q1 		– Sell
-4,140
Closed -$1.11M – 10364
2021
Q4 		$1.11M Sell
4,140
-2,307
-36% -$605K ﹤0.01% 5678
2021
Q3 		$1.88M Buy
6,447
+3,057
+90% +$892K ﹤0.01% 4596
2021
Q2 		$839K Buy
3,390
+930
+38% +$239K ﹤0.01% 6215
2021
Q1 		$704K Sell
2,460
-2,187
-47% -$873K ﹤0.01% 6158
2020
Q4 		$1.3M Sell
4,647
-3,790
-45% -$1.4M ﹤0.01% 4241
2020
Q3 		$3.44M Sell
8,437
-4,110
-33% -$2.11M ﹤0.01% 2269
2020
Q2 		$7.28M Buy
12,547
+2,284
+22% +$1.04M 0.01% 1439
2020
Q1 		$2.35M Buy
+10,263
New +$1.78M ﹤0.01% 1865

Other funds holding CODX

PAG
Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SAM
Smartleaf Asset Management Boston, Massachusetts $2.77B AUM 22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Jane Street's CODX Position: Q1 2026 in Review

Jane Street sold out of Co-Diagnostics (CODX) in Q1 2026, closing a stake of 8,031 shares — an estimated $40.6K sold.

Jane Street first reported a position in CODX in Q1 2020 and held it in 17 quarters. The position peaked at $793K in Q3 2020. 14 funds tracked by Wall St. Rank hold CODX as of Q1 2026.

  • Jane Street reported no remaining Co-Diagnostics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 8,031 Co-Diagnostics shares in Q1 2026, an estimated $40.6K.
  • Jane Street first reported a position in Co-Diagnostics in Q1 2020 and held it in 17 quarters.
  • Jane Street's Co-Diagnostics position peaked at $793K in Q3 2020.
  • 14 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.